<img alt="" src="https://secure.wake4tidy.com/244317.png" style="display:none;">
2022-08-15

Publication of SimSearch study demonstrating values of AI in microscopy

We are happy to announce the official publication of the study "SimSearch: A Human-in-the-loop learning framework for fast detection of regions of interest in microscopy images”, demonstrating Vironova’s technology leadership in AI-based research...

2022-07-01

Ida-Maria Sintorn promoted Professor at Uppsala University

Vironova is proud to announce the promotion of its Chief Technology Officer (CTO) Ida-Maria Sintorn to Professor of Computerized Image Processing at Uppsala University, Department of Information Technology, as of 1 July, 2022.  

2022-06-27

Vironova in collaboration for simplified production of gene therapy vectors

GeneNova, a new innovation milieu with the goal to develop novel production methods for adeno-associated virus based gene therapies, has just been launched.  

2022-06-15

Annual General Meeting 2022 - Vironova AB

2020-06-15: Shareholders of Vironova AB (publ), 556678-1463, are hereby summoned to our annual general meeting which will be held on July 15 , 2022, at 14:00 at the company´s premise at Gävlegatan 22, Stockholm.

2022-06-14

Annual General Meeting 2022 for Vironova AB will be held July 15th

2020-06-14: The Annual General Meeting will be moved from June 30, 2022 to July 15, 2022 at 14.00. A new notice of the Annual General Meeting will be issued shortly. The Annual General Meeting will be held at the company's premises at Gävlegatan 22...

2022-06-07

Vironova/Takeda study demonstrates a validated cryoTEM-based method to analyze genome packaging in recombinant AAVs

We are happy to present a joint Vironova/Takeda study (PLoS ONE 17(6): e0269139) demonstrating a validated cryogenic TEM-based (cryoTEM) method to visualize, quantify, and assess the genome packaging in recombinant adeno-associated virus (rAAV)...

2022-05-30

New scientific publication showing Vironova’s technology leadership in AI research

New scientific publication showing Vironova’s technology leadership in AI research for bioimage applications and engagement in academic-industry collaboration. Access the paper ahead of publication.

2022-04-20

Prevas acquires Vironova AB's subsidiary BitSim NOW AB

Prevas has signed an agreement for the acquisition of 100 percent of BitSim NOW AB. BitSim NOW is a consulting firm in Stockholm with 35 employees focusing on innovative product development.

2022-04-04

Master thesis at Vironova Research and Innovation

Vironova is looking for enthusiastic master students to work on a semester thesis research project. You will get the opportunity to meet the Research & Innovation team of Vironova and learn about the work performed within an exciting biotechnology...

2022-03-17

Major shareholders in alignment to create a stronger Vironova

The Board of Directors has been in contact with the major shareholders and has decided in a positive spirit that it will work towards a broadening of the Board of Directors, increased financial information and a greater spread of Class A shares in...

1 2 3 4 5